Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gerson

Showing results (231-240 of 257) with videos related to

Pageof 26
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2015
Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk PatientsPaolo F Caimi, Basem M William, Carlos H Silva Rondon, et al.
Plos One|May 19, 2022
15-PGDH regulates hematopoietic and gastrointestinal fitness during agingWon Jin Ho, Julianne N P Smith, Young Soo Park, et al.
American Journal of Hematology|April 28, 2009
Elevated AF1q expression is a poor prognostic marker for adult acute myeloid leukemia patients with normal cytogeneticsCrawford J Strunk, Uwe Platzbecker, Christian Thiede, et al.
Scientific Reports|November 26, 2015
Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachoneGaurab Chakrabarti, Molly A Silvers, Mariya Ilcheva, et al.
Cancer Research|January 22, 2015
Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistanceValery Adorno-Cruz, Golam Kibria, Xia Liu, et al.
Progress in Biophysics and Molecular Biology|March 6, 2021
An effective human uracil-DNA glycosylase inhibitor targets the open pre-catalytic active site conformationMy T Nguyen, Davide Moiani, Zamal Ahmed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
A phase I and pharmacodynamic study of fludarabine, carboplatin, and topotecan in patients with relapsed, refractory, or high-risk acute leukemiaBrenda W Cooper, Gareth J Veal, Tomas Radivoyevitch, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 23, 2005
Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patientsHillard M Lazarus, Omer N Koc, Steven M Devine, et al.
Investigational New Drugs|October 12, 2012
A phase 1 study of TRC102, an inhibitor of base excision repair, and pemetrexed in patients with advanced solid tumorsMichael S Gordon, Lee S Rosen, David Mendelson, et al.
Investigational New Drugs|June 20, 2020
Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumorsJennifer R Eads, Smitha S Krishnamurthi, Joel Saltzman, et al.
Pageof 26

Showing results (231-240 of 257) with videos related to

Sort By:
Pageof 26
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2015
Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk PatientsPaolo F Caimi, Basem M William, Carlos H Silva Rondon, et al.
Plos One|May 19, 2022
15-PGDH regulates hematopoietic and gastrointestinal fitness during agingWon Jin Ho, Julianne N P Smith, Young Soo Park, et al.
American Journal of Hematology|April 28, 2009
Elevated AF1q expression is a poor prognostic marker for adult acute myeloid leukemia patients with normal cytogeneticsCrawford J Strunk, Uwe Platzbecker, Christian Thiede, et al.
Scientific Reports|November 26, 2015
Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachoneGaurab Chakrabarti, Molly A Silvers, Mariya Ilcheva, et al.
Cancer Research|January 22, 2015
Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistanceValery Adorno-Cruz, Golam Kibria, Xia Liu, et al.
Progress in Biophysics and Molecular Biology|March 6, 2021
An effective human uracil-DNA glycosylase inhibitor targets the open pre-catalytic active site conformationMy T Nguyen, Davide Moiani, Zamal Ahmed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
A phase I and pharmacodynamic study of fludarabine, carboplatin, and topotecan in patients with relapsed, refractory, or high-risk acute leukemiaBrenda W Cooper, Gareth J Veal, Tomas Radivoyevitch, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 23, 2005
Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patientsHillard M Lazarus, Omer N Koc, Steven M Devine, et al.
Investigational New Drugs|October 12, 2012
A phase 1 study of TRC102, an inhibitor of base excision repair, and pemetrexed in patients with advanced solid tumorsMichael S Gordon, Lee S Rosen, David Mendelson, et al.
Investigational New Drugs|June 20, 2020
Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumorsJennifer R Eads, Smitha S Krishnamurthi, Joel Saltzman, et al.
Pageof 26